Page last updated: 2024-08-23

etoposide and folic acid

etoposide has been researched along with folic acid in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.00)18.7374
1990's3 (12.00)18.2507
2000's5 (20.00)29.6817
2010's16 (64.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belinsky, MG; Chen, ZS; Kruh, GD; Rea, PA; Zeng, H1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Miyachi, H; Ohnuma, T; Sekiguchi, S; Takemura, Y1
Bennett, M; Buamah, PK; James, OF; Lendrum, R; McArdle, P1
Falk, M; Fridrik, MA; Haidinger, R; Hausmaninger, H; Klocker, J; Linkesch, W; Neubauer, M; Pont, J; Radaszkiewicz, T; Raudaschl, G; Schiller, L; Seewann, HL; Sill, H; Stöger, M1
Lurain, JR1
Clarke-Pearson, DL; Kirkpatrick, JP; Sampson, JH; Soper, JT; Spillman, M; Wolf, JK1
Patlolla, RR; Vobalaboina, V1
Drossopoulou, GI; Kontoyianni, C; Paleos, CM; Sideratou, Z1
Demirbilek, M; Denkbas, EB; Güven, E; Hazer, B; Kılıçay, E; Türk, M1
Firozian, F; Hassanzadeh, F; Sadeghi-Aliabadi, H; Varshosaz, J1
Chen, YC; Kuo, YC1
Kuo, YC; Lee, CH1
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Ramírez, LA1
Jiang, H; Li, J; Lu, C; Zhang, S; Zhang, X1
Li, JC; Liang, L; Sun, L; Tian, Y; Zhang, HM; Zhu, JX; Zhu, N1
Chen, W; Clement, S; Deng, W; Engel, A; Goldys, EM; Guller, A; Zhao, Z1
Alibolandi, M; Dinari, M; Khayamian, T; Ramezani, M; Rezaei, B; Shamili, FH; Shirani, MP1
Chang, YH; Kuo, YC; Rajesh, R1
Rajput, SJ; Saroj, S1

Reviews

2 review(s) available for etoposide and folic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Management of high-risk gestational trophoblastic disease.
    The Journal of reproductive medicine, 1998, Volume: 43, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine

1998

Trials

1 trial(s) available for etoposide and folic acid

ArticleYear
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Feasibility Studies; Female; Folic Acid; Hematologic Diseases; Humans; Ifosfamide; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Remission Induction; Risk Factors; Survival Rate; Vincristine

1996

Other Studies

22 other study(ies) available for etoposide and folic acid

ArticleYear
Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
    Cancer research, 2001, Oct-01, Volume: 61, Issue:19

    Topics: 3T3 Cells; Animals; ATP-Binding Cassette Transporters; Biological Transport; Drug Resistance, Multiple; Folic Acid; Humans; Leucovorin; Methotrexate; Mice; Multidrug Resistance-Associated Proteins; Osmolar Concentration; Polyglutamic Acid; Tritium

2001
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717).
    Journal of cancer research and clinical oncology, 1991, Volume: 117, Issue:6

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Line; Cisplatin; Cross Reactions; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Folic Acid; Humans; Leucovorin; Membrane Glycoproteins; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; RNA, Messenger; Thymidylate Synthase; Trimetrexate; Vincristine

1991
A pleomorphic hepatocellular carcinoma with biochemical features of fibrolamellar hepatocellular carcinoma.
    Journal of surgical oncology, 1986, Volume: 32, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Neurotensin; Quinazolines; Vitamin B 12

1986
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
    Gynecologic oncology, 2007, Volume: 104, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Staging; Pregnancy; Radiosurgery; Risk Factors; Vincristine

2007
Folate-targeted etoposide-encapsulated lipid nanospheres.
    Journal of drug targeting, 2008, Volume: 16, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Compounding; Etoposide; Fluorescent Dyes; Folic Acid; Humans; KB Cells; Lipids; Mice; Microscopy, Fluorescence; Nanospheres; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Soybean Oil; Tissue Distribution

2008
Synthesis of a folate functionalized PEGylated poly(propylene imine) dendrimer as prospective targeted drug delivery system.
    Bioorganic & medicinal chemistry letters, 2010, Nov-15, Volume: 20, Issue:22

    Topics: Antineoplastic Agents; Cell Line, Tumor; Dendrimers; Drug Delivery Systems; Etoposide; Folic Acid; Humans; Magnetic Resonance Spectroscopy; Polyethylene Glycols; Polypropylenes; Solubility; Spectrophotometry, Ultraviolet

2010
Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2011, Oct-09, Volume: 44, Issue:3

    Topics: 3-Hydroxybutyric Acid; Animals; Antineoplastic Agents; Apoptosis; Caproates; Cell Survival; Drug Carriers; Drug Compounding; Etoposide; Fibroblasts; Folic Acid; HeLa Cells; Humans; Immunohistochemistry; Ligands; Mice; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties

2011
Uptake of etoposide in CT-26 cells of colorectal cancer using folate targeted dextran stearate polymeric micelles.
    BioMed research international, 2014, Volume: 2014

    Topics: Binding, Competitive; Cell Death; Cell Line, Tumor; Colorectal Neoplasms; Dextrans; Etoposide; Fluorescence; Folic Acid; Humans; Inhibitory Concentration 50; Micelles; Microscopy, Electron, Transmission; Polymers; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Stearates

2014
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    International journal of pharmaceutics, 2015, Feb-01, Volume: 479, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Delivery Systems; Endothelial Cells; Etoposide; Folate Receptors, GPI-Anchored; Folic Acid; Glioblastoma; Humans; Lactic Acid; Lactoferrin; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; Topoisomerase II Inhibitors

2015
Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Etoposide; Folic Acid; Glioblastoma; Humans; Lipids; Mannose; Nanoparticles

2015
Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia.
    Gynecologic oncology, 2015, Volume: 138, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian; Black or African American; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Risk Factors; White People; Young Adult

2015
Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
    Drug delivery, 2016, Volume: 23, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Etoposide; Folic Acid; Humans; Lipids; Mice; Nanomedicine; Nanostructures; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols

2016
Folic Acid-Targeted Etoposide Cubosomes for Theranostic Application of Cancer Cell Imaging and Therapy.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, May-22, Volume: 23

    Topics: Animals; Calorimetry, Differential Scanning; Cell Death; Cell Survival; Diagnostic Imaging; Drug Delivery Systems; Drug Liberation; Etoposide; Folic Acid; Humans; Inhibitory Concentration 50; Liquid Crystals; MCF-7 Cells; Mice; Neoplasms; Particle Size; Proton Magnetic Resonance Spectroscopy; Static Electricity; Theranostic Nanomedicine

2017
Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation.
    Nature communications, 2018, 07-13, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Combined Modality Therapy; Delayed-Action Preparations; Doxorubicin; Drug Liberation; Etoposide; Fluoresceins; Folic Acid; Gene Silencing; Gold; HCT116 Cells; Humans; Liposomes; Metal Nanoparticles; Mice; Oligoribonucleotides, Antisense; PC12 Cells; Photochemotherapy; Photosensitizing Agents; Rats; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Singlet Oxygen; Verteporfin; X-Rays; Xenograft Model Antitumor Assays

2018
Ingenious pH-sensitive etoposide loaded folic acid decorated mesoporous silica-carbon dot with carboxymethyl-βcyclodextrin gatekeeper for targeted drug delivery and imaging.
    Materials science & engineering. C, Materials for biological applications, 2018, Nov-01, Volume: 92

    Topics: beta-Cyclodextrins; Carbon; Drug Delivery Systems; Etoposide; Folic Acid; HeLa Cells; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Nanoparticles; Silicon Dioxide

2018
Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)‑poly(ε‑caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid.
    Materials science & engineering. C, Materials for biological applications, 2019, Volume: 96

    Topics: Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Etoposide; Folic Acid; Glioblastoma; Humans; Nanoparticles; Polyesters; Polyethylene Glycols; Wheat Germ Agglutinins

2019
Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup3

    Topics: Cell Line, Tumor; Drug Carriers; Etoposide; Folic Acid; Humans; Male; Nanoparticles; Prostatic Neoplasms; Silicon Dioxide

2018